Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
10%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
HART
75
HOLDINGS
6%
ALSO IN XPH
XPH
47
HOLDINGS
9%
ALSO IN HART
SECTOR DRIFT (HART minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
| JOHNSON & JOHNSON | 5.6% | 2.8% | 2.8% | |
| ELI LILLY & CO | 4.5% | 2.7% | 2.7% | |
| PFIZER INC | 4.7% | 2.6% | 2.6% | |
| BRISTOL-MYERS SQUIBB CO | 3.9% | 2.4% | 2.4% | |
HART Overweight Relative to XPH
| ALPHABET INC. CLASS A | 6.8% | |
| NOVARTIS AG | 6.0% | |
| ASTRAZENECA PLC | 5.9% | |
| BOSTON SCIENTIFIC CORP | 5.8% | |
| ABBOTT LABORATORIES | 5.5% | |
| MEDTRONIC PLC | 5.3% | |
| APPLE INC | 4.9% | |
| SANOFI-AVENTIS | 3.2% | |
| JOHNSON & JOHNSON | 2.8% | |
| NIKE INC -CL B | 2.6% |
HART Underweight Relative to XPH
| TARSUS PHARMACEUTICALS, INC. | -3.4% | |
| CRINETICS PHARMACEUTICALS INC | -3.0% | |
| ELANCO ANIMAL HEALTH, INC. | -3.0% | |
| CORCEPT THERAPEUTICS INC | -2.8% | |
| LIGAND PHARMACEUTICALS-CL B | -2.8% | |
| SUPERNUS PHARMACEUTICALS INC | -2.8% | |
| JAZZ PHARMACEUTICALS PLC | -2.7% | |
| AXSOME THERAPEUTICS, INC. | -2.6% | |
| ROYALTY PHARMA PLC CLASS A | -2.6% | |
| MERCK & CO. INC. | -2.6% |